C4 Therapeutics (C4T) is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases, reduce drug resistance, achieve higher potency, and decrease side effects through greater selectivity.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
May 30, 2023
May 4, 2023
Apr 19, 2023
April 26, 2023 at 11:00 AM EDT
February 21, 2023 at 12:00 PM EST
February 15, 2023 at 3:00 PM EST